Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 Weeks
Apply
Remibrutinib & Omalizumab
Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 Weeks
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step